Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Viva Biotech Holdings (HK:1873)
:1873
Holding HK:1873?
Track your performance easily
1873 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.41 - HK$1.22
Previous CloseN/A
Volume129.00K
Average Volume (3M)1.47M
Market Cap
HK$1.72B
Enterprise ValueHK$1.64B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.95
Next Earnings
Mar 27, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 16, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,161,366,200
10 Day Avg. Volume980,450
30 Day Avg. Volume1,467,997
Standard Deviation0.19
R-Squared0.29
Alpha-0.00586
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.96
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Viva Biotech Holdings News
PremiumCompany Announcements
Viva Biotech Announces Subsidiary Restructuring and CFO Changes
PremiumCompany Announcements
Viva Biotech Reports Strong Profit Growth
PremiumCompany Announcements
Viva Biotech Plans Strategic Share Buyback
PremiumCompany Announcements
Viva Biotech Plans Board Meeting for Financial Review
PremiumCompany Announcements
Viva Biotech Corrects Clerical Error in Key Document
PremiumCompany Announcements
Viva Biotech Shareholders Approve Key ResolutionsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.28% Mutual Funds
0.01% Other Institutional Investors
99.65% Public Companies and
Individual Investors
1873 FAQ
What was Viva Biotech Holdings’s price range in the past 12 months?
Viva Biotech Holdings lowest stock price was HK$0.41 and its highest was HK$1.22 in the past 12 months.
What is Viva Biotech Holdings’s market cap?
Viva Biotech Holdings’s market cap is HK$1.72B.
When is Viva Biotech Holdings’s upcoming earnings report date?
Viva Biotech Holdings’s upcoming earnings report date is Mar 27, 2025 which is in 64 days.
How were Viva Biotech Holdings’s earnings last quarter?
Viva Biotech Holdings released its earnings results on Aug 29, 2024. The company reported HK$0.053 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.053.
Is Viva Biotech Holdings overvalued?
According to Wall Street analysts Viva Biotech Holdings’s price is currently Overvalued.
Does Viva Biotech Holdings pay dividends?
Viva Biotech Holdings pays a Annually dividend of HK$0.009 which represents an annual dividend yield of N/A. See more information on Viva Biotech Holdings dividends here
What is Viva Biotech Holdings’s EPS estimate?
Viva Biotech Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Viva Biotech Holdings have?
Viva Biotech Holdings has 2,161,366,200 shares outstanding.
What happened to Viva Biotech Holdings’s price movement after its last earnings report?
Viva Biotech Holdings reported an EPS of HK$0.053 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.961%.
Which hedge fund is a major shareholder of Viva Biotech Holdings?
Currently, no hedge funds are holding shares in HK:1873
---
Viva Biotech Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.89%
12-Months-Change
Fundamentals
Return on Equity
<0.01%
Trailing 12-Months
Asset Growth
-12.23%
Trailing 12-Months
Company Description
Viva Biotech Holdings
Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Drug discovery services segment. The Drug discovery services segment includes structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage innovative drug development.
---
Technical Analysis
Li Bao Ge Group Ltd.
―
Budweiser Brewing Co. APAC Ltd.
―
Guan Chao Holdings Limited
―
China New Higher Education Group Ltd
―
Janco Holdings Limited
―
---